InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,459.10
(
1.11%
)
US TECH 100
18,514.00
(
1.00%
)
Dow Jones
40,589.34
(
1.64%
)
Brent Oil
79.75
(
0.00%
)
Bitcoin
67,742.33
(
-0.09%
)
Post# of 252710
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

biophud

Send PM Follow Ignore
Followers 0
Posts 394
Boards Moderated 0
Alias Born 08/12/2006

biophud

Re: DewDiligence post# 59716

Friday, 02/29/2008 10:13:31 PM

Friday, February 29, 2008 10:13:31 PM

Post# of 252710
Dew--thanks for your comments on ALNY.
Regarding point#5--"RSV vaccines are available commercially."

Is this a reference to Synagis? Synagis is an ant-RSV MAB that produces passive immunological protection? Synagis is not a vaccine.

My understanding is that MEDI (now AZN) is/was working on a RSV vaccine.

Regards,

biophud
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up